Marlowe PLC Further re Acquisition of William Martin (3955Y)

TIDMMRL

RNS Number : 3955Y

Marlowe PLC

09 September 2020

9 September 2020

Marlowe plc

Further re Acquisition of William Martin

Total Voting Rights

Marlowe plc (" Marlowe " or the " Group "), the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that, further to the Group's announcement dated 21 December 2018 and pursuant to the put and call mechanism described therein, Marlowe has settled the deferred consideration for William Martin Compliance Limited (" William Martin ").

The total deferred consideration of approximately GBP3.35 million comprises a cash payment of GBP1.5 million and the issue of 365,613 new ordinary shares of GBP0.50 each in the capital of Marlowe (" Consideration Shares "). The Consideration Shares are subject to a lock-in, pursuant to which they may not be sold, transferred or otherwise disposed of at any time prior to 1 May 2021. Save for in certain circumstances, 50% of the Consideration Shares may not be sold, transferred or otherwise disposed of at any time prior to 1 May 2022.

Total Voting Rights

Application has been made for the Consideration Shares to be admitted to trading on AIM, and it is expected that admission will occur at 8.00 a.m. on or around 14 September 2020. Following admission of the Consideration Shares, the Company's issued ordinary share capital will comprise 54,825,420 ordinary shares, each with voting rights.

Therefore, the figure of 54,825,420 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

 
 Marlowe plc                               www.marloweplc.com 
 Alex Dacre, Chief Executive               Tel: [phone] 
                                            6194 
 Mark Adams, Group Finance Director        [e-mail] 
 
 Cenkos Securities plc - Nominated Adviser & Joint Broker 
 Nicholas Wells                            Tel: [phone] 
                                            8900 
 Ben Jeynes 
 Harry Hargreaves 
 
 Joh. Berenberg, Gossler & Co. KG, London Branch - Joint Broker 
 Mark Whitmore                             Tel: [phone] 
  Ben Wright                                7800 
 Yudith Karunaratna 
 
 FTI Consulting 
 Nick Hasell                               Tel: [phone] 
                                            1340 
 Alex Le May 
 

About Marlowe plc

Marlowe is a UK leader in specialist services which assure safety and regulatory compliance, whilst managing risk for businesses across the country. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated inspection, testing and compliance services. It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & hygiene, air quality and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 15% of Britain's commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQUWABRRNUKRAR

(END) Dow Jones Newswires

September 09, 2020 02:00 ET (06:00 GMT)